Literature DB >> 22308296

HIF-1α deletion partially rescues defects of hematopoietic stem cell quiescence caused by Cited2 deficiency.

Jinwei Du1, Yu Chen, Qiang Li, Xiangzi Han, Cindy Cheng, Zhengqi Wang, David Danielpour, Sally L Dunwoodie, Kevin D Bunting, Yu-Chung Yang.   

Abstract

Cited2 is a transcriptional modulator involved in various biologic processes including fetal liver hematopoiesis. In the present study, the function of Cited2 in adult hematopoiesis was investigated in conditional knockout mice. Deletion of Cited2 using Mx1-Cre resulted in increased hematopoietic stem cell (HSC) apoptosis, loss of quiescence, and increased cycling, leading to a severely impaired reconstitution capacity as assessed by 5-fluorouracil treatment and long-term transplantation. Transcriptional profiling revealed that multiple HSC quiescence- and hypoxia-related genes such as Egr1, p57, and Hes1 were affected in Cited2-deficient HSCs. Because Cited2 is a negative regulator of HIF-1, which is essential for maintaining HSC quiescence, and because we demonstrated previously that decreased HIF-1α gene dosage partially rescues both cardiac and lens defects caused by Cited2 deficiency, we generated Cited2 and HIF-1α double-knockout mice. Additional deletion of HIF-1α in Cited2-knockout BM partially rescued impaired HSC quiescence and reconstitution capacity. At the transcriptional level, deletion of HIF-1α restored expression of p57 and Hes1 but not Egr1 to normal levels. Our results suggest that Cited2 regulates HSC quiescence through both HIF-1-dependent and HIF-1-independent pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22308296      PMCID: PMC3327457          DOI: 10.1182/blood-2011-10-387902

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity.

Authors:  P C Mahon; K Hirota; G L Semenza
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

2.  Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia.

Authors:  Nobuhito Goda; Heather E Ryan; Bahram Khadivi; Wayne McNulty; Robert C Rickert; Randall S Johnson
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

3.  Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator.

Authors:  S D Bamforth; J Bragança; J J Eloranta; J N Murdoch; F I Marques; K R Kranc; H Farza; D J Henderson; H C Hurst; S Bhattacharya
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

4.  Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival.

Authors:  Lara Tickenbrock; Hans-Ulrich Klein; Cristina Trento; Antje Hascher; Stefanie Göllner; Nicole Bäumer; Robert Kuss; Shuchi Agrawal; Gesine Bug; Hubert Serve; Christian Thiede; Gerhard Ehninger; Udo Zur Stadt; Michael McClelland; Yipeng Wang; Anke Becker; Steffen Koschmieder; Wolfgang E Berdel; Martin Dugas; Carsten Müller-Tidow
Journal:  Leuk Res       Date:  2010-12-22       Impact factor: 3.156

5.  VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages.

Authors:  Pantelis Georgiades; Sarah Ogilvy; Hélène Duval; Diana R Licence; D Stephen Charnock-Jones; Stephen K Smith; Cristin G Print
Journal:  Genesis       Date:  2002-12       Impact factor: 2.487

6.  Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.

Authors:  H E Ryan; M Poloni; W McNulty; D Elson; M Gassmann; J M Arbeit; R S Johnson
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

7.  The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation.

Authors:  Zhan Yin; Jennifer Haynie; Xiaoming Yang; Baoguang Han; Songsak Kiatchoosakun; Joseph Restivo; Saying Yuan; Nanduri R Prabhakar; Karl Herrup; Ronald A Conlon; Brian D Hoit; Michiko Watanabe; Yu-Chung Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

8.  Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.

Authors:  Steven J Freedman; Zhen-Yu J Sun; Andrew L Kung; Dennis S France; Gerhard Wagner; Michael J Eck
Journal:  Nat Struct Biol       Date:  2003-07

9.  Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice.

Authors:  Elena Almarza; José Carlos Segovia; Guillermo Guenechea; Susana G Gómez; Angel Ramírez; Juan Antonio Bueren
Journal:  Exp Hematol       Date:  2004-04       Impact factor: 3.084

10.  E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9.

Authors:  Matthew J Oberley; David R Inman; Peggy J Farnham
Journal:  J Biol Chem       Date:  2003-08-08       Impact factor: 5.157

View more
  31 in total

Review 1.  Genetic control of quiescence in hematopoietic stem cells.

Authors:  Takeshi Yamada; Chun Shik Park; H Daniel Lacorazza
Journal:  Cell Cycle       Date:  2013-06-28       Impact factor: 4.534

2.  Cited2 is required for the maintenance of glycolytic metabolism in adult hematopoietic stem cells.

Authors:  Jinwei Du; Qiang Li; Fangqiang Tang; Michelle A Puchowitz; Hisashi Fujioka; Sally L Dunwoodie; David Danielpour; Yu-Chung Yang
Journal:  Stem Cells Dev       Date:  2013-11-12       Impact factor: 3.272

Review 3.  Metabolic requirements for the maintenance of self-renewing stem cells.

Authors:  Keisuke Ito; Toshio Suda
Journal:  Nat Rev Mol Cell Biol       Date:  2014-04       Impact factor: 94.444

4.  CITED2 Restrains Proinflammatory Macrophage Activation and Response.

Authors:  Gun-Dong Kim; Riku Das; Xiaoquan Rao; Jixin Zhong; Jeffrey A Deiuliis; Diana L Ramirez-Bergeron; Sanjay Rajagopalan; Ganapati H Mahabeleshwar
Journal:  Mol Cell Biol       Date:  2018-02-12       Impact factor: 4.272

5.  Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury.

Authors:  Lijian Shao; Yingying Wang; Jianhui Chang; Yi Luo; Aimin Meng; Daohong Zhou
Journal:  Transl Cancer Res       Date:  2013-10       Impact factor: 1.241

6.  Stepwise cell fate decision pathways during osteoclastogenesis at single-cell resolution.

Authors:  Masayuki Tsukasaki; Nam Cong-Nhat Huynh; Kazuo Okamoto; Ryunosuke Muro; Asuka Terashima; Yoshitaka Kurikawa; Noriko Komatsu; Warunee Pluemsakunthai; Takeshi Nitta; Takaya Abe; Hiroshi Kiyonari; Tadashi Okamura; Mashito Sakai; Toshiya Matsukawa; Michihiro Matsumoto; Yasuhiro Kobayashi; Josef M Penninger; Hiroshi Takayanagi
Journal:  Nat Metab       Date:  2020-12-07

7.  CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.

Authors:  P M Korthuis; G Berger; B Bakker; M Rozenveld-Geugien; J Jaques; G de Haan; J J Schuringa; E Vellenga; H Schepers
Journal:  Leukemia       Date:  2014-09-03       Impact factor: 11.528

Review 8.  Regulation of cell proliferation by hypoxia-inducible factors.

Authors:  Maimon E Hubbi; Gregg L Semenza
Journal:  Am J Physiol Cell Physiol       Date:  2015-10-21       Impact factor: 4.249

9.  Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells.

Authors:  Yin Wang; Yan Liu; Fei Tang; Kelsie M Bernot; Reuven Schore; Guido Marcucci; Michael A Caligiuri; Pan Zheng; Yang Liu
Journal:  Blood       Date:  2014-07-03       Impact factor: 22.113

10.  Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.

Authors:  Stéphane Prost; Francis Relouzat; Marc Spentchian; Yasmine Ouzegdouh; Joseph Saliba; Gérald Massonnet; Jean-Paul Beressi; Els Verhoeyen; Victoria Raggueneau; Benjamin Maneglier; Sylvie Castaigne; Christine Chomienne; Stany Chrétien; Philippe Rousselot; Philippe Leboulch
Journal:  Nature       Date:  2015-09-02       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.